NDC 68071-4963-01 - Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68071-4963
- Requested NDC
- 68071-4963-01
- Package NDCs from labels
- 68071-4963-9, 68071-4963-1, 68071-4963-01
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Effective date
- 2025-06-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| HYDROCHLOROTHIAZIDE TABLETS USP 2083 2089 Rx only | NuCare Pharmaceuticals,Inc. | 2025-06-27 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2023-02-02 | HYDROCHLOROTHIAZIDE TABLETS USP 2083 2089 Rx only |
| 2023-01-30 | HYDROCHLOROTHIAZIDE TABLETS USP 2083 2089 Rx only |
| 2021-02-18 | HYDROCHLOROTHIAZIDE TABLETS USP 2083 2089 Rx only |
| 2021-01-29 | HYDROCHLOROTHIAZIDE TABLETS USP 2083 2089 Rx only |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-4963-1 | Hydrochlorothiazide | 20 in 1 BOTTLE | TABLET | 20 | 6 | |
| 68071-4963-9 | Hydrochlorothiazide | 90 in 1 BOTTLE | TABLET | 90 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-4963 | HYDROCHLOROTHIAZIDE TABLET [NUCARE PHARMACEUTICALS,INC.] | 5 | Current NDC, Legacy NDC, 2 package rows | 20250105_8d5a9196-5f1d-2d83-e053-2a95a90a6036.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | QPharma, Inc. | c9c44c37-bb49-4364-9293-3c8fd51b759e | 2025-12-16 | Warnings, Adverse reactions | ANDA083177 310798 0J48LPH2TH |
| INZIRQO | HYDROCHLOROTHIAZIDE | ANI Pharmaceuticals, Inc. | 41aaea48-6c1b-42c8-a96f-5923d49dc934 | 2025-12-16 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | QPharma, Inc. | 9cd5d16e-3db7-4b25-847d-6de91543463b | 2025-12-15 | Warnings, Adverse reactions | 310798 0J48LPH2TH |
| Exforge HCT | AMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDE | Novartis Pharmaceuticals Corporation | 18d7820d-471f-4ee2-9ec6-25d8d27c77de | 2025-12-12 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Chartwell RX, LLC | 4e43dd27-3f4b-4205-a26e-6ecaa8281347 | 2025-12-10 | Warnings, Adverse reactions | 310798 0J48LPH2TH |
| TRIAMTERENE AND HYDROCHLOROTHIAZIDE | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Chartwell RX, LLC | 261dd83f-8048-488f-8b71-c4abd9692720 | 2025-12-10 | Adverse reactions | 0J48LPH2TH |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Lifestar Pharma LLC | 9771066e-c05d-6a93-e053-2995a90a7e87 | 2025-12-09 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Spironolactone and Hydrochlorothiazide | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | Sun Pharmaceutical Industries, Inc. | d7fa3c79-9f26-415b-8039-eb2acabcf66b | 2025-12-09 | Warnings, Adverse reactions | 0J48LPH2TH |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | QPharma Inc | 578f74ea-53d1-4c44-b872-66033292abe0 | 2025-12-05 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | QPharma Inc | ff7b2d81-9006-465d-9095-1bd8696a12a6 | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | QPharma, Inc. | 5bacc909-6b02-4815-85ef-55fd25b1b1f7 | 2025-12-05 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Jubilant Cadista Pharmaceuticals Inc. | e0b74a86-3d36-1af0-e538-41b45b8d2cc3 | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril/HCTZ | LISINOPRIL/HCTZ | Direct_Rx | 4510c108-2683-f505-e063-6394a90ab0a4 | 2025-12-03 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | QPharma Inc | f795db5e-d5ef-4a20-e053-6394a90a7fda | 2025-12-03 | Warnings, Adverse reactions | 310798 0J48LPH2TH |
| Losartan potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | f5f462c6-0604-49d3-af8f-fecbde23be99 | 2025-12-03 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Hikma Pharmaceuticals USA Inc. | 17561aae-f0bc-4ffc-a007-985b17e9baf0 | 2025-12-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL, AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE | Micro Labs Limited | 9fb71df8-f70f-47dc-9465-8d8748261caf | 2025-11-29 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Benazepril Hydrochloride and Hydrochlorothiazide | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | ANI Pharmaceuticals, Inc. | e6527adf-8c74-4d81-9199-d56a7fca895e | 2025-11-26 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYZAAR | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Organon LLC | 4116ccde-2e23-45f4-b12f-6337df877744 | 2025-11-26 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Lupin Pharmaceuticals, Inc. | 515f735c-5dba-43d9-8a58-97a319cafd56 | 2025-11-24 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.